DES MOINES, Iowa (KCCI/CNN/CNN Newsource/WKRC) — A new leukemia drug is offering hope to families. Four-year-old Madi Seivert's love for shopping is more than just child's play. Her favorite accessory ...

ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia . Clinical data showing unprecedented remission rates in newly diagnosed AML patient ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

But it is less well known that Iran also targets Israeli medical research-ers. To focus on just one group, Iran had a devastating effect on leukemia researchers during the 12-day war.

Scientists at Indiana University School of Medicine have identified a new approach that could transform treatment for acute ...

The patients receiving AHSCT had 5-year LFS of 46.3% and OS of 53.3%, which were better outcomes than those of the MRC UKALL XII/ECOG E2993 trial conducted from 2006 to 2010.

Henry Repeating Arms has donated a limited run of 50 “Team Keane” Golden Boy .22 lever-action rifles to support 13-year-old ...

A groundbreaking drug, blinatumomab, is transforming leukemia treatment, offering new hope for patients like 4-year-old Madi ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

The FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.